J. Goldman & Co’s Medtronic MDT Stock Holding History

J. Goldman & Co’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,300	Closed	-$166K	–	292
2014 Q4	$166K	Hold	2,300	–	–	0.02%	173
2014 Q3	$142K	Buy	+2,300	New	+$146K	0.01%	267

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

J. Goldman & Co's MDT Position: Q2 2026 in Review

J. Goldman & Co sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,392 shares — an estimated $207K sold.

J. Goldman & Co first reported a position in MDT in Q3 2013 and held it in 6 quarters. The position peaked at $12.7M in Q4 2013. 2,135 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

J. Goldman & Co reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
J. Goldman & Co sold 2,392 Medtronic shares in Q2 2026, an estimated $207K.
J. Goldman & Co first reported a position in Medtronic in Q3 2013 and held it in 6 quarters.
J. Goldman & Co's Medtronic position peaked at $12.7M in Q4 2013.
2,135 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.